One of the molecular pathogenesis of the elevated risk of SPBC in thyroid cancer patients could be the high ER levels in thyroid cancer patients compared with the general population in whom sex steroid receptors are present in human thyroid tissue [25, 26]. Here, ESR1 is linked to thyroid gland carcinoma.